UK scientists have discovered a new treatment for asthma and COPD, marking a significant breakthrough in 50 years. The study shows that benralizumab, a monoclonal antibody, is more effective than steroids in managing symptoms and reducing the need for additional treatments. The trial involved high-risk patients and indicated that benralizumab could improve respiratory outcomes and reduce hospital visits. Teljes cikk (Euronews.com)